Maraviroc-d6

• CAT Number: R009798
• CAS Number: 1033699-22-7
• Molecular Formula: C₂₉H₃₅D₆F₂N₅O
• Molecular Weight: 519.7
• Purity: ≥95%
• Synonyms: 4,4-Difluoro-N-[(1S)-3-[(3-exo)-3-[3-methyl-5-(1-methylethyl-d6)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]oct-8-yl]-1-phenylpropyl]cyclohexanecarboxamide; UK 427857-d6
• Storage: -20°C
• IUPAC Name: 4,4-difluoro-N-[(1S)-3-[(1R,5S)-3-[3-(1,1,1,3,3,3-hexadeuteriopropan-2-yl)-5-methyl-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]cyclohexane-1-carboxamide
• InChI: InChI=1S/C29H41F2N5O/c1-19(2)27-34-33-20(3)36(27)25-17-23-9-10-24(18-25)35(23)16-13-26(21-7-5-4-6-8-21)32-28(37)22-11-14-29(30,31)15-12-22/h4-8,19,22-26H,9-18H2,1-3H3,(H,32,37)/t23-,24+,25?,26-/m0/s1/i1D3,2D3
• InChIKey: GSNHKUDZZFZSJB-ICIYIAOWSA-N
• SMILES: [2H]C([2H])([2H])C(C1=NN=C(N1C2C[C@H]3CC[C@@H](C2)N3CC[C@@H](C4=CC=CC=C4)NC(=O)C5CCC(CC5)(F)F)C)C([2H])([2H])[2H]

Maraviroc-d6 is a deuterated form of maraviroc, a CCR5 antagonist used in the treatment of HIV-1 infection. In this compound, six hydrogen atoms are replaced with deuterium, enhancing its stability and enabling precise analysis in pharmacokinetic and metabolic studies. The deuterium labeling allows for accurate tracking of the compound using mass spectrometry, making Maraviroc-d6 particularly valuable in research focused on the absorption, distribution, metabolism, and excretion (ADME) of maraviroc. This isotopically labeled version is essential for studying drug interactions, optimizing dosing regimens, and ensuring the safety and efficacy of maraviroc in HIV therapy. It provides reliable data that supports the development and refinement of antiretroviral treatments.